Oncology (Switzerland)

Aims & Scope

Although laboratory and clinical cancer research need to be closely linked, ob­servations at the basic level often remain removed from medical applications.

This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation.

The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease.

The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena.

A unique feature of the journal is a section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.8
2024	2.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.747

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	110

Journal Rank

Year	Value
2024	7445

Journal Citation Indicator

Year	Value
2024	572

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• VEGF as a Key Mediator of Angiogenesis in Cancer

  Citation: 1342

  Authors: Peter

• Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients

  Citation: 567

  Authors: M., P., P., J., C., M.

• Biology of HER2 and Its Importance in Breast Cancer

  Citation: 526

  Authors: Yosef

• Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

  Citation: 506

  Authors: O., M., P., T., D., M., R., R.

• VEGF as a Therapeutic Target in Cancer

  Citation: 468

  Authors: Napoleone

• Results of a Nationwide Study on the Three-Field Lymph Node Dissection of Esophageal Cancer

  Citation: 390

  Authors: Kaichi, Hiroshi, Komei

• Global Epidemiology of Head and Neck Cancers: A Continuing Challenge

  Citation: 377

  Authors: Bhawna, Newell W., Narinder

• The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer

  Citation: 346

  Authors: Takeharu, Shigemi, Satoshi, Ryota, Yoji, Masanori

• Interleukin-6: A Masterplayer in the Cytokine Network

  Citation: 346

  Authors: Peter, Wolfram C.M.

• EGFR Signaling and Drug Discovery

  Citation: 331

  Authors: Georg, Heinz-Josef

---